• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Femasys Inc. - Common Stock (NQ:FEMY)

    2.090 -0.290 (-12.18%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Femasys Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    News headline image
    Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
    Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centers 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
    From Femasys Inc.
    Via GlobeNewswire
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
    -- Modular PMA pathway advances FemBloc toward potential U.S. approval while Femasys builds commercial infrastructure across its reproductive health portfolio -- 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Regains Compliance with Nasdaq Listing Requirements
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗
    Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements in the global healthcare market. 
    Via The Motley Fool
    Topics Regulatory Compliance
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    News headline image
    Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
    -- New catheter complements FemVue® and supports streamlined in-office fertility evaluation -- 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
    -- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices -- 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
    Expanding commercialization of first-line fertility treatment in the OB/GYN office to increase patient access 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
    -- Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval -- 
    From Femasys Inc.
    Via GlobeNewswire
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
    -- Multi-Product Distribution Agreement Marks Continued Commercial Momentum in Europe -- 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
    Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large, engaged patient population 
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. 
    Via Chartmill
    News headline image
    Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.